|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement显示文摘Alcoholic liver disease encompasses a broad spectrum of diseases ranging from steatosis steatohepatitis,fibrosis,and cirrhosis to hepatocellular carcinoma.Forty-four per cent of all deaths from cirrhosis are attributed to alcohol.Alcoholic liver disease is the second most common diagnosis among patients undergoing liver transplantation(LT).The vast majority of transplant programmes(85%)require 6 mo of abstinence prior to transplantation;commonly referred to as the'6-mo rule'.Both in the case of progressive end-stage liver disease(ESLD)and in the case of severe acute alcoholic hepatitis(AAH),not responding to medical therapy,there is a lack of evidence to support a 6-mo sobriety period.It is necessary to identify other risk factors that could be associated with the resumption of alcohol drinking.The'Group of Italian Regions'suggests that:in a case of ESLD with model for end-stage liver disease<19 a 6-mo abstinence period is required;in a case of ESLD,a 3-mo sober period before LT may be more ideal than a 6-mo period,in selected patients;and in a case of severe AAH,not respond-ing to medical therapies(up to 70%of patients die within 6 mo),LT is mandatory,even without achieving abstinence.The multidisciplinary transplant team must include an addiction specialist/hepato-alcohologist.Patients have to participate in self-help groups. | Gianni Testino Patrizia Burra Ferruccio Bonino Francesco Piani Alessandro Sumberaz Roberto Peressutti Andrea Giannelli Castiglione Valentino Patussi Tiziana Fanucchi Ornella Ancarani Giovanna De Cerce Anna Teresa Iannini Giovanni Greco Antonio Mosti Marilena Durante Paola Babocci Mariano Quartini Davide Mioni Sarino Aricò Aniello Baselice Silvia Leone Fabiola Lozer Emanuele Scafato Paolo Borro | 2014 | World Journal of Gastroenterology2014，20，40： | 5 |
| 2 | Type-2 hepatorenalsyndrome and refractory ascites:role of transjugularintrahepatic portosystemic stent-shunt in eighteen patientswith advanced cirrhosis awaiting orthotopic livertransplantation显示文摘 | Testino G Ferro C Sumberaz A | 2003 | Hepatogastroenterology2003，50，54： | 1 |
| 3 | Liver Transplantation in Alcoholic Patients显示文摘 | Gianni Testino Silvia Leone Alessandro Sumberaz Paolo Borro | 2014 | Alcohol Clin Exp Res2014，，6： | 1 |
| 4 | Recurrent hepatitis C and non-alcoholic fatty liver disease in transplanted patients: a review显示文摘 | Testino G Sumberaz A Leone S | 2013 | Minerva Med2013，104，2： | 1 |
| 5 | Type 2 hepatorenal syndrome and refractory ascites:role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation显示文摘 | Testino G Ferro C Sumberaz A | 2003 | Hepatogastroenterology2003，50，54： | 1 |
| 6 | Pegylated interferon (PEG-IFN) alfa-2b and ribavirin for recurrent hepatitis C (genotype 1) after liver transplantation: Relationship with steatosis显示文摘 | Gianni Testino Alessandro Sumberaz | 2006 | Digestive and Liver Disease2006，，11： | 1 |
| 7 | Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation 显示文摘 | Testino G Ferro C Sumberaz A | 2003 | Hepatogastroenterology2003，50，54： | 1 |
| 8 | Comment to “Liver transplantation for patients with alcoholic liver disease: An open question”显示文摘 | Gianni Testino Alessandro Sumberaz Paolo Borro | 2013 | Digestive and Liver Disease2013，，1： | 1 |
| 9 | Type-2 hepatorenal syndrome and refractory ascites: role of transjugu]ar intrahepatic portosystemicstent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation 显示文摘 | Testino G Ferro C Sumberaz A | 2003 | Heparogastroenterology2003，50，54： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员